This supplier has worked with different contracting methods. The distribution of contracts by method shows the diversity of competitiveness with the public sector.
| Method | # Contracts |
|---|---|
| direct | 6 |

Octapharma GmbH appears in the public procurement registry of Germany. Public procurement is the process by which the State acquires goods and services using public funds; its publication is mandatory in most countries to ensure transparency and allow citizens to oversee public spending. This registry documents the individuals and companies that are part of that system. The data in this profile comes from official government sources, accessible through Sociedad.info, a public procurement transparency platform.
Has participated in 6 contracts for a total amount of EUR 1,287,000
Full reports for this country will be available soon. Leave your email and we will notify you when they are ready.
This company has participated in 6 public contracts for a total amount of EUR 1,287,000, demonstrating its ability to work with the public sector.
Public contracts represent an important source of income for companies in Germany and contribute to the country's economic development.
| Description | Entity | Amount | Award date |
|---|---|---|---|
| 🇩🇪 Arzneimittelrabattvereinbarung nach SS 130 a Abs. 8 SGB V zu den Wirkstoffen Blutgerinnungsfaktor IX, VIII sowie von Willebrand-Faktor und Blutgerinnungsfaktor VIII in Kombination | AOK Baden-Württemberg | EUR 214,000 | 2021-05-14 |
| 🇩🇪 Arzneimittelrabattvereinbarung nach SS 130 c Abs. 1 SGB V zum Wirkstoff Simoctocog alfa | AOK Baden-Württemberg | EUR 214,000 | 2021-05-14 |
| 🇩🇪 Arzneimittelrabattvertrag nach SS 130a Abs. 8 SGB V i.V.m. SS 130c Abs. 1 SGB V zu Arzneimitteln zur Behandlung der Hamophilie | AOK Sachsen - Anhalt | EUR 215,000 | 2023-09-06 |
| 🇩🇪 Arzneimittelrabattvereinbarung nach SS 130c Abs. 1 SGB V zum Wirkstoff Simoctocog alfa | AOK Baden-Württemberg | EUR 215,000 | 2023-08-28 |
| 🇩🇪 Arzneimittelrabattvereinbarung nach SS 130a Abs. 8 SGB V zu den Wirkstoffen Blutgerinnungsfaktor IX, VIII sowie von Willebrand-Faktor und Blutgerinnungsfaktor VIII in Kombination | AOK Baden-Württemberg | EUR 215,000 | 2023-08-28 |
This supplier has worked with different contracting methods. The distribution of contracts by method shows the diversity of competitiveness with the public sector.
| Method | # Contracts |
|---|---|
| direct | 6 |
Main buyers are the entities that have contracted this supplier the most.
| Entidad | No. Contracts | Total amount |
|---|---|---|
| 🇩🇪 AOK Baden-Württemberg | 5 | EUR 1,072,000 |
| 🇩🇪 AOK Sachsen - Anhalt | 1 | EUR 215,000 |
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
